RØYRVIK ET AL.112. Io<strong>no</strong>v Y, Matsui S, Cowell JK. A role for p300/CREB b<strong>in</strong>d<strong>in</strong>g prote<strong>in</strong> genes <strong>in</strong>promot<strong>in</strong>g cancer progression <strong>in</strong> colon cancer cell l<strong>in</strong>es with microsatellite <strong>in</strong>stability.Proc Natl Acad Sci U S A. 2004;101:1273–8.113. Laghi L, Ranzani GN, Bianchi P, Mori A, He<strong>in</strong>imann K, Orbetegli O, SpaudoMR, Lu<strong>in</strong>etti O, Francisconi S, Roncalli M, Solcia E, Malesci A. Frameshiftmutations of human gastr<strong>in</strong> receptor gene (hGARE) <strong>in</strong> gastro<strong>in</strong>test<strong>in</strong>al cancerswith microsatellite <strong>in</strong>stability. Lab Invest. 2002;82:265–71.114. Wick<strong>in</strong>g C, Simms LA, Evans T, Walsh M, Chawengsaksophak K, Beck F,Chenevix-Trench G, Young J, Jass J, Leggett B, Wa<strong>in</strong>wright B. CDX2, a humanhomologue of Drosophila caudal, is mutated <strong>in</strong> both alleles <strong>in</strong> a replicationerror positive colorectal cancer. Oncogene. 1998;17:657–9.115. El-Bchiri J, Buhard O, Penard-Lacronique V, Thomas G, Hamel<strong>in</strong> R, Duval A.Differential <strong>no</strong>nsense mediated decay of mutated mRNAs <strong>in</strong> mismatch repairdeficient colorectal cancers. Hum Mol Genet. 2005;14:2435–42.116. Yoshitaka T, Matsubara N, Ikeda M, Tan<strong>in</strong>o M, Hanafusa H, Tanaka N, ShimizuK. Mutations of E2F-4 tr<strong>in</strong>ucleotide repeats <strong>in</strong> colorectal cancer with microsatellite<strong>in</strong>stability. Biochem Biophys Res Commun. 1996;227:553–7.117. Ikeda M, Orimo H, Moriyama H, Nakajima E, Matsubara N, Mibu R, TanakaN, Shimada T, Kimura A, Shimizu K. Close correlation between mutations ofE2F4 <strong>and</strong> hMSH3 genes <strong>in</strong> colorectal cancers with microsatellite <strong>in</strong>stability.Cancer Res. 1998;58:594–8.118. Alazzouzi H, Davalos V, Kokko A, Dom<strong>in</strong>go E, Woerner SM, Wilson AJ,Konrad L, Laiho P, Esp<strong>in</strong> E, Armengol M, Imai K, Yamamoto H, MariadasonJM, Gebert JF, Aaltonen LA, Schwartz S Jr, Arango D. Mechanisms of <strong>in</strong>activatio<strong>no</strong>f the receptor tyros<strong>in</strong>e k<strong>in</strong>ase EPHB2 <strong>in</strong> colorectal tumors. Cancer Res.2005;65:10170–3.119. Forgacs E, Wren JD, Kamibayashi C, Kondo M, Xu XL, Markowitz S,Toml<strong>in</strong>son GE, Muller CY, Gazdar AF, Garner HR, M<strong>in</strong>na JD. Search<strong>in</strong>g formicrosatellite mutations <strong>in</strong> cod<strong>in</strong>g regions <strong>in</strong> lung, breast, ovarian <strong>and</strong> colorectalcancers. Oncogene. 2001;20:1005–9.120. Swisher EM, Mutch DG, Herzog TJ, Rader JS, Kowalski LD, Elbendary A,Goodfellow PJ. Analysis of MSH3 <strong>in</strong> endometrial cancers with defective DNAmismatch repair. J Soc Gynecol Investig. 1998;5:210–6.121. Orimo H, Nakajima E, Ikejima M, Emi M, Shimada T. Frameshift mutations<strong>and</strong> a length polymorphism <strong>in</strong> the hMSH3 gene <strong>and</strong> the spectrum of microsatellite<strong>in</strong>stability <strong>in</strong> sporadic colon cancer. Jpn J Cancer Res. 1999;90:1310–5.122. Akiyama Y, Nagasaki H, Nakajima T, Sakai H, Nomizu T, Yuasa Y. Infrequentframeshift mutations <strong>in</strong> the simple repeat sequences of hMLH3 <strong>in</strong> hereditary<strong>no</strong>npolyposis colorectal cancers. Jpn J Cl<strong>in</strong> Oncol. 2001;31:61–4.252
TARGET GENES OF MSI COLORECTAL CANCER123. Ohmiya N, Matsumoto S, Yamamoto H, Bara<strong>no</strong>vskaya S, Malkhosyan SR, PeruchoM. Germl<strong>in</strong>e <strong>and</strong> somatic mutations <strong>in</strong> hMSH6 <strong>and</strong> hMSH3 <strong>in</strong> gastro<strong>in</strong>test<strong>in</strong>alcancers of the microsatellite mutator phe<strong>no</strong>type. Gene. 2001;272:301–13.124. Ouyang H, Shiwaku HO, Hagiwara H, Miura K, Abe T, Kato Y, Ohtani H,Shiiba K, Souza RF, Meltzer SJ, Horii A. The <strong>in</strong>sul<strong>in</strong>-like growth factor II receptorgene is mutated <strong>in</strong> <strong>genetic</strong>ally unstable cancers of the endometrium,stomach, <strong>and</strong> colorectum. Cancer Res. 1997;57:1851–4.125. Bader S, Walker M, Hendrich B, Bird A, Bird C, Hooper M, Wyllie A. Somaticframeshift mutations <strong>in</strong> the MBD4 gene of sporadic colon cancers with mismatchrepair deficiency. Oncogene. 1999;18:8044–7.126. Riccio A, Aaltonen LA, Godw<strong>in</strong> AK, Loukola A, Percesepe A, Salovaara R,Masciullo V, Genuardi M, Paravatou-Petsotas M, Bassi DE, Ruggeri BA,Kle<strong>in</strong>-Szanto AJ, Testa JR, Neri G, Bellacosa A. The DNA repair gene MBD4(MED1) is mutated <strong>in</strong> human carc<strong>in</strong>omas with microsatellite <strong>in</strong>stability. NatGenet. 1999;23:266–8.127. Yamada T, Koyama T, Ohwada S, Tago K, Sakamoto I, Yoshimura S, HamadaK, Takeyoshi I, Morishita Y. Frameshift mutations <strong>in</strong> the MBD4/MED1 gene<strong>in</strong> primary gastric cancer with high-frequency microsatellite <strong>in</strong>stability. CancerLett. 2002;181:115–20.128. P<strong>in</strong>to M, Wu Y, Suria<strong>no</strong> G, Mens<strong>in</strong>k RG, Duval A, Oliveira C, Carvalho B,Hamel<strong>in</strong> R, Seruca R, Hofstra RM. MBD4 mutations are rare <strong>in</strong> gastric carc<strong>in</strong>omaswith microsatellite <strong>in</strong>stability. Cancer Genet Cytogenet. 2003;145:103–7.129. Loukola A, Vilkki S, S<strong>in</strong>gh J, Lau<strong>no</strong>nen V, Aaltonen LA. Germl<strong>in</strong>e <strong>and</strong> somaticmutation analysis of MLH3 <strong>in</strong> MSI-positive colorectal cancer. Am JPathol. 2000;157:347–52.130. Giann<strong>in</strong>i G, Ristori E, Cerig<strong>no</strong>li F, R<strong>in</strong>aldi C, Zani M, Viel A, Ott<strong>in</strong>i L, CrescenziM, Mart<strong>in</strong>otti S, Bignami M, Frati L, Screpanti I, Gul<strong>in</strong>o A. HumanMRE11 is <strong>in</strong>activated <strong>in</strong> mismatch repair-deficient cancers. EMBO Rep.2002;3:248–54.131. Ott<strong>in</strong>i L, Falchetti M, Saieva C, De MM, Masala G, Zanna I, Paglierani M,Giann<strong>in</strong>i G, Gul<strong>in</strong>o A, Nesi G, Mariani CR, Palli D. MRE11 expression is impaired<strong>in</strong> gastric cancer with microsatellite <strong>in</strong>stability. Carc<strong>in</strong>ogenesis.2004;25:2337–43.132. Giann<strong>in</strong>i G, R<strong>in</strong>aldi C, Ristori E, Ambros<strong>in</strong>i MI, Cerig<strong>no</strong>li F, Viel A, Bidoli E,Berni S, D'Amati G, Scambia G, Frati L, Screpanti I, Gul<strong>in</strong>o A. Mutations ofan <strong>in</strong>tronic repeat <strong>in</strong>duce impaired MRE11 expression <strong>in</strong> primary human cancerwith microsatellite <strong>in</strong>stability. Oncogene. 2004;23:2640–7.253
- Page 1 and 2:
Novel genetic and epigenetic altera
- Page 3 and 4:
TABLE OF CONTENTSACKNOWLEDGEMENTS .
- Page 5 and 6:
ACKNOWLEDGEMENTSThe present work ha
- Page 7 and 8:
Prefacetechnology[3]. This new tech
- Page 10 and 11:
SummaryThe subgroup of carcinomas w
- Page 12 and 13:
Introduction“Epigenetic inheritan
- Page 14 and 15:
Introductionamino acid change it is
- Page 16 and 17:
Introductionmethylation during embr
- Page 18 and 19:
IntroductionDNA is most of the time
- Page 20 and 21:
IntroductionFigure 5. DNA methylati
- Page 22 and 23:
IntroductionFigure 6. Incidence rat
- Page 24 and 25:
IntroductionFigure 8. Tumor staging
- Page 26 and 27:
Introductioninasmuch as 80% of colo
- Page 28 and 29:
IntroductionInstabilities involved
- Page 30 and 31:
Introductionthere seems to be a fid
- Page 32 and 33:
Introductionsevere alterations are
- Page 34 and 35:
Introductionpopulation-wide screeni
- Page 36 and 37:
IntroductionFigure 12. Present and
- Page 38 and 39:
RESULTS IN BRIEFPaper Ia. “DNA hy
- Page 40 and 41:
Results in Briefinstability, and se
- Page 42 and 43:
Results in BriefUnivariate survival
- Page 44 and 45:
Discussionseveral factors, and full
- Page 46 and 47:
Discussionlow threshold, we increas
- Page 48 and 49:
DiscussionIt may seem like unnecess
- Page 50 and 51:
Discussionthan 96% DHPLC do not sta
- Page 52 and 53:
DiscussionFigure 13. Mutation detec
- Page 54 and 55:
DiscussionClinical impact of molecu
- Page 56 and 57:
Discussionmarkers with a very high
- Page 58 and 59:
Discussionchromosomes in metaphase[
- Page 60 and 61:
DiscussionThese examples underline
- Page 62 and 63:
Discussiongenes. One is based on mu
- Page 64 and 65:
CONCLUSIONSWe have identified novel
- Page 66 and 67:
Future PerspectivesMolecular risk a
- Page 68 and 69:
REFERENCES1. Breasted J (1930) The
- Page 70 and 71:
References29. Deng G, Chen A, Pong
- Page 72 and 73:
References57. Al-Sukhni W, Aronson
- Page 74 and 75:
References84. Kunkel TA (1993) Nucl
- Page 76 and 77:
ReferencesLeggett B, Levine J, Kim
- Page 78 and 79:
References133. Lind GE, Thorstensen
- Page 80 and 81:
References156. Meling GI, Lothe RA,
- Page 82 and 83:
ReferencesT, Song X, Day RH, Sledzi
- Page 84 and 85:
References196. Honda S, Haruta M, S
- Page 86 and 87:
ORIGINAL ARTICLESAPPENDIXAppendix I
- Page 89 and 90:
GASTROENTEROLOGY 2007;132:1631-1639
- Page 91:
Paper IbGuro E Lind, Terje Ahlquist
- Page 94 and 95:
Journal of Translational Medicine 2
- Page 96 and 97:
Journal of Translational Medicine 2
- Page 98 and 99:
Journal of Translational Medicine 2
- Page 100 and 101:
Journal of Translational Medicine 2
- Page 102 and 103:
Journal of Translational Medicine 2
- Page 105:
Paper IITerje Ahlquist, Guro E Lind
- Page 108 and 109:
BackgroundMost cases of colorectal
- Page 110 and 111:
ADAMTS1 CDKN2A CRABP1 HOXA9 MAL MGM
- Page 112 and 113:
pseudogene, leading to a high rate
- Page 114 and 115:
strands. Proc Natl Acad Sci U S A 1
- Page 116 and 117:
concomitant absence of transcript a
- Page 119 and 120:
Volume 10 Number 7 July 2008 pp. 68
- Page 121 and 122:
682 RAS Signaling in Colorectal Car
- Page 123 and 124:
684 RAS Signaling in Colorectal Car
- Page 125 and 126:
686 RAS Signaling in Colorectal Car
- Page 127:
Table W2. Detailed Somatic Events o
- Page 131 and 132:
Identification of RCC2 as a prognos
- Page 133 and 134:
INTRODUCTIONMicrosatellite instabil
- Page 135 and 136: unselected series of primary tumors
- Page 137 and 138: specificity, i.e. that they only am
- Page 139 and 140: On the assumption that DNA repair a
- Page 141 and 142: In order to ensure that gene mutati
- Page 143 and 144: Figure 2. Mutation frequency differ
- Page 145 and 146: and TAF1B (0.50), ACVR2A and ASTE1
- Page 147 and 148: Multivariate analysesA multivariate
- Page 149 and 150: When comparing our findings of muta
- Page 151 and 152: The test series included a low numb
- Page 153 and 154: entering M-phase remains to be seen
- Page 155 and 156: 12. Duval A, Reperant M, Hamelin R
- Page 157 and 158: 34. Martineau-Thuillier S, Andreass
- Page 159: AppendicesAppendix I:List of abbrev
- Page 163 and 164: Critical Reviews TM in Oncogenesis,
- Page 165 and 166: TARGET GENES OF MSI COLORECTAL CANC
- Page 167 and 168: TARGET GENES OF MSI COLORECTAL CANC
- Page 169 and 170: TARGET GENES OF MSI COLORECTAL CANC
- Page 171 and 172: TARGET GENES OF MSI COLORECTAL CANC
- Page 173 and 174: TARGET GENES OF MSI COLORECTAL CANC
- Page 175 and 176: TARGET GENES OF MSI COLORECTAL CANC
- Page 177 and 178: TARGET GENES OF MSI COLORECTAL CANC
- Page 179 and 180: TARGET GENES OF MSI COLORECTAL CANC
- Page 181 and 182: TARGET GENES OF MSI COLORECTAL CANC
- Page 183 and 184: TARGET GENES OF MSI COLORECTAL CANC
- Page 185: TARGET GENES OF MSI COLORECTAL CANC
- Page 189 and 190: TARGET GENES OF MSI COLORECTAL CANC
- Page 191: TARGET GENES OF MSI COLORECTAL CANC